Clinical Trial Update: Feasibility of FMISO in Brain Tumors [Phase 2]

View source ↗

Summary

This is a Phase 2 feasibility study evaluating FMISO PET imaging in malignant brain neoplasms, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• FMISO (fluoromisonidazole)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Malignant Brain Neoplasm | Phase 2 | Status: RECRUITING